Tekton Research

Austin, Texas 98745

3 studies enrolling now · 50 studies all time

What they study most

Acute Migraine, Ankylosing Spondylitis, Anthrax, Asthma, Atopic Dermatitis, COVID-19, COVID-19 Disease, Chronic Gout, Dengue, Dengue Fever, Diabetes Mellitus, Type 2, Episodic Migraine

Studies at this site

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• ConsideRAte Study - Splenic Stimulation for RA — Recruiting now
• A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age — Stopped early
• Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination — Running, not enrolling
• VELOCITY: An Anthrax Vaccine Clinical Study — Completed
• A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee — Completed
• Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults — Completed
• Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis — Running, not enrolling
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis — Completed
• A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes — Completed
• A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults — Completed
• A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine — Completed
• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines — Completed
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) — Completed
• ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 — Completed
• A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT) — Completed
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. — Completed
• A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain — Completed
• A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 — Completed
• A Study of ARRY-502 in Patients With Persistent Asthma — Completed
• A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy — Completed
• Safety and Efficacy in Adult Subjects With Acute Migraines — Completed
• Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee — Stopped early
• AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee — Completed
• Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults — Running, not enrolling
• Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants — Completed
• Cantharidin Application in Molluscum Patients — Completed
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine — Completed
• Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) — Completed
• Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection — Stopped early
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention — Completed
• Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis — Stopped early
• Evaluating New Formulation of Therapeutic HSV-2 Vaccine — Completed
• Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity — Completed
• Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study — Completed
• Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine — Completed
• Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis — Completed
• Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee — Completed
• Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) — Completed
• A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years — Completed
• Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention — Status unconfirmed
• Hymovis™ Versus Placebo in Knee Osteoarthritis — Completed